Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection

Clinical Microbiology and Infection

Volumn 12, Issue 11, 2006, Pages 1077-1081

  Kong, X ^a   Xiao, T ^a   Lin, J ^a   Wang, Y ^a   Chen, H D ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Clinical forms; Mice; RAPD typing; Sporothrix schenckii; Typing; Virulence

Indexed keywords

FUNGAL DNA; GENOMIC DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; FUNGAL GENE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SKIN INFECTION; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS;

SPOROTHRIX SCHENCKII;

EID: 33749060806     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01519.x     Document Type: Article

References (20)

1. Altner PC, Turner RR. Sporotrichosis of bones and joints. Review of the literature and report of six cases. Clin Orthop 1970; 68: 138-148.
2. England DM, Hochholzer L. Sporotrichosis infection of the lung without cutaneous disease. Arch Pathod Laboratory Med 1987; 111: 298-300.
3. Scott EN, Muchmore HG. Sporotrichosis. In: Murphy JW, Friedman H, Bendinelli M, eds, Fungal infections and immune responses. New York: Plenum Press, 1993; 135-150.
4. Shiraishi A, Nakagaki K, Arai T. Experimental sporotrichosis in congenital athymic (nude) mice. J Recticuloendothlial Soc 1979; 26: 333-336.
5. Dickerson CL, Taylor RL, Drutz DJ. Suseptibility of congenital athymic (nude) mice to sporotrichosis. Infect Immun 1983; 40: 417-420.
6. Shiraishi A, Nakagaki K, Arai T. Role of cell mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 1992; 120: 15-21.
7. Penn CC, Goldstein E, Bartholomew WR. Sporothrix schenckii meningitis in a patient with AIDS. Clin Infect Dis 1992; 15: 741-743.
8. Donabedian H, O'Donnell E, Olszewski C, Macarthur RD, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diag Microbial Infect Dis 1994; 18: 111-115.
9. Morgan M, Reves R. Invasive sinusitis due to Sporothrix schenckii in a patient with. AIDS. Clin Infect Dis 1996; 23: 1319-1320.
10. Ware AJ, Cockerell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am Acad Dermatol 1999; 40: 350-355.
11. Doldani LZ, Aquino VR, Dargel AA. Disseminated cutaneous sporotrichosis in an AIDS patient receiving maintenance therapy with fluconazole for previous cryptococcal meningitis. Clin Infect Dis 1999; 28: 1337-1338.
12. Tachibana T, Matsuyama T, Mitsuyama M. Characteristic infectivity of Sporothrix schenckii to mice depending on routes of infection and inherent fungal pathogenicity. Med Mycol 1998; 36: 21-27.
13. Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4 T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999; 37: 397-404.
14. Granham GC, Mayers P, Henry RJ. A simplified method for the preparation of fungal genomic DNA and RAPD analysis. Biotechniques 1994; 16: 48-50.
15. Mesa-Arango AC, del Reyes M, Perez-mejie A. Phenotyping and genotyping of Sporothrix schenkii isolates according to geographic origin and clinical form of sporotrichosis. J Clin Microbiol 2002; 40: 3004-3011.
16. Ishizaki H, Kawasaki M, Aoki M, Miyaji M, Nishimura K, Garcia Fernandez JA. Mitochondrial DNA analysis of Sporothrix schenckii in Costa Rica. J Med Vet Mycol 1996; 34: 71-73.
17. Ishizaki H, Kawasaki M, Aoki M et al. Mitochondrial DNA analysis of Sporothrix schenckii in North and South America. Mycopathologia 1998; 142: 115-118.
18. Travassos LR, Lloyd KO. Sporothrix schenckii and related species of ceratocystis. Microbiol Rev 1980; 44: 683-721.
19. Rippon JW. Sporotrichosis in medical mycology, 3rd edn. Philadelphia: Saunders, 1988.
20. Tachibana T, Matsuyama T, Ito M, Mitsuyama M. Sporothrix schenckii thermo-intolerent mutant losing fatal visceral infectivity but retaining high cutaneous infectivity. Med Mycol 2001; 39: 295-298.